ZLD 24.8% 75.5¢ zelira therapeutics limited

Proactive investor today, page-7

  1. 1,316 Posts.
    lightbulb Created with Sketch. 488
    Agreed -

    cannibas is legal, industry wont stop now, clinically prooven, gmp grade, differentiated options will float to the top of consumer choice.

    zeliras clinically validated products, revenues, plus p2 trials should see thing become pretty valuable.

    well played ...
 
watchlist Created with Sketch. Add ZLD (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.